Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design

INTRODUCTION: Cotrimoxazole (CTX) prophylaxis is recommended by the World Health Organisation for HIV infected persons. However, once HIV infected patients have commenced ART in resource limited settings, the benefits of continued CTX prophylaxis are not known. The few studies that investigated the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Contemp Clin Trials
Egile Nagusiak: Anywaine, Zacchaeus, Abaasa, Andrew, Levin, Jonathan, Kasirye, Ronnie, Kamali, Anatoli, Grosskurth, Heiner, Munderi, Paula, Nunn, Andrew
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4542218/
https://ncbi.nlm.nih.gov/pubmed/26009024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2015.05.015
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak